• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:关于侵袭性高级别膀胱尿路上皮癌转化为肠型腺癌的综合病例研究及综合治疗方法。

Case Report: A comprehensive case study on aggressive high-grade urothelial carcinoma of bladder that transforms into enteric-type adenocarcinoma along with an integrated treatment approach.

作者信息

Rahul Neha, Jules Manishimwe, Weerarathna Induni Nayodhara, Luharia Anurag, Dube Prashik

机构信息

Department of Radio Oncology, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, India.

Department of Radiotherapy, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, India.

出版信息

Front Radiol. 2025 Jun 9;5:1586440. doi: 10.3389/fradi.2025.1586440. eCollection 2025.

DOI:10.3389/fradi.2025.1586440
PMID:40552193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12183188/
Abstract

Bladder cancer is a malignant tumour with a high morbidity and mortality rate in the world. Moreover, it is the most prevalent as well as commonly diagnosed in older individuals, with a median age of 73 years, and it has been reported that the most frequently seen histological type of bladder cancer was urothelial carcinoma. We present a unique case of a 44-year-old female with enteric-type adenocarcinoma, a rare and aggressive bladder cancer. Her symptoms included frequent micturition (Urination) and hematuria (blood in urine), at which point she was diagnosed with High-grade urothelial carcinoma. The malignancy worsened despite cycles of treatment requiring extensive surgery. After further tests, it was found that she had urothelial carcinoma with features of intestinal tissue (tissue of the intestine) and that the disease had infiltrated into nearby blood vessels and nerves. Radiation therapy was recommended to decrease the risk of local recurrence after surgery. The challenges in treating such a patient and the positive aspects this approach can give are highlighted in a case report.

摘要

膀胱癌是一种在全球发病率和死亡率都很高的恶性肿瘤。此外,它在老年人中最为普遍且最常被诊断出,中位年龄为73岁,据报道,膀胱癌最常见的组织学类型是尿路上皮癌。我们报告一例独特的病例,一名44岁女性患有肠型腺癌,这是一种罕见且侵袭性强的膀胱癌。她的症状包括尿频(排尿)和血尿(尿液中带血),此时她被诊断为高级别尿路上皮癌。尽管经过了多次需要广泛手术的治疗周期,恶性肿瘤仍在恶化。进一步检查后发现,她患有具有肠道组织(肠组织)特征的尿路上皮癌,并且疾病已浸润到附近的血管和神经。建议进行放射治疗以降低术后局部复发的风险。一份病例报告突出了治疗此类患者的挑战以及这种方法可能带来的积极方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/a95e66deccbf/fradi-05-1586440-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/56a80b5d90ad/fradi-05-1586440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/d9516ea7d431/fradi-05-1586440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/39a7237ceb8a/fradi-05-1586440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/a95e66deccbf/fradi-05-1586440-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/56a80b5d90ad/fradi-05-1586440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/d9516ea7d431/fradi-05-1586440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/39a7237ceb8a/fradi-05-1586440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28d/12183188/a95e66deccbf/fradi-05-1586440-g004.jpg

相似文献

1
Case Report: A comprehensive case study on aggressive high-grade urothelial carcinoma of bladder that transforms into enteric-type adenocarcinoma along with an integrated treatment approach.病例报告:关于侵袭性高级别膀胱尿路上皮癌转化为肠型腺癌的综合病例研究及综合治疗方法。
Front Radiol. 2025 Jun 9;5:1586440. doi: 10.3389/fradi.2025.1586440. eCollection 2025.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

本文引用的文献

1
Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives.改善膀胱癌放疗反应的实验研究综述:评论与展望
Cancers (Basel). 2020 Dec 30;13(1):87. doi: 10.3390/cancers13010087.
2
Targets for Therapy of Bladder Cancer.膀胱癌治疗靶点。
Semin Nucl Med. 2020 Mar;50(2):162-170. doi: 10.1053/j.semnuclmed.2020.02.006. Epub 2020 Feb 29.
3
Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites.对 472 例不同分级和解剖部位的尿路上皮癌的突变分析。
Clin Cancer Res. 2019 Apr 15;25(8):2458-2470. doi: 10.1158/1078-0432.CCR-18-3147. Epub 2018 Dec 28.
4
Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations.初诊 T1 高级别膀胱尿路上皮癌的治疗策略:新见解和更新建议。
Eur Urol. 2018 Nov;74(5):597-608. doi: 10.1016/j.eururo.2018.06.024. Epub 2018 Jul 13.
5
Perspective: Bridging the gender gap.观点:弥合性别差距。
Nature. 2017 Nov 8;551(7679):S39. doi: 10.1038/551S39a.
6
Urothelial Carcinoma and its Variants.
Surg Pathol Clin. 2008 Dec;1(1):159-209. doi: 10.1016/j.path.2008.07.004. Epub 2008 Dec 6.
7
The management of BCG failure in non-muscle-invasive bladder cancer: an update.非肌层浸润性膀胱癌中卡介苗治疗失败的管理:最新进展
Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S199-205. doi: 10.5489/cuaj.1196.
8
Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.肌肉浸润性膀胱癌的新辅助化疗和辅助化疗
Eur Urol. 2009 Feb;55(2):348-58. doi: 10.1016/j.eururo.2008.10.016. Epub 2008 Oct 16.